The Lancet. Infectious Diseases
-
Publication Venue For
-
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial..
20:80-91.
2020
-
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium..
19:e405-e421.
2019
-
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis..
19:546-556.
2019
-
Maternal immunisation to improve the health of HIV-exposed infants..
19:e120-e131.
2019
-
Maternal immunisation and neonatal infection of hepatitis A or B virus - Authors' reply..
19:238-239.
2019
-
Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis..
19:143-155.
2019
-
Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection)..
18:845-853.
2018
-
Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem..
18:e107-e118.
2018
-
Pigs, pathogens, and public health..
18:372-373.
2018
-
Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial..
17:1255-1265.
2017
-
Fungal infections in HIV/AIDS..
17:e334-e343.
2017
-
Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply..
17:1123-1124.
2017
-
Successful cure of extensively drug-resistant pulmonary tuberculosis in a young child..
17:898-899.
2017
-
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study..
16:1364-1376.
2016
-
Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review..
16:e178-e189.
2016
-
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis..
16:828-837.
2016
-
Emerging tick-borne infections in mainland China: an increasing public health threat..
15:1467-1479.
2015
-
Artemisinin resistance in Myanmar..
15:1001-1002.
2015
-
Bacterial meningitis in the USA..
15:508-509.
2015
-
A closer inspection of tedizolid - authors' reply..
15:375.
2015
-
Emerging viral respiratory tract infections--environmental risk factors and transmission..
14:1113-1122.
2014
-
Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections--needs, advances, and future prospects..
14:1123-1135.
2014
-
Surveillance for emerging respiratory viruses..
14:992-1000.
2014
-
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial..
14:696-705.
2014
-
Lyme disease vaccination: safety first - author's reply..
14:13.
2014
-
Lyme disease vaccination: are we ready to try again?.
13:643-644.
2013
-
Boceprevir for HCV in patients with HIV: where next?.
13:563-564.
2013
-
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial..
13:401-408.
2013
-
Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis..
12:457-468.
2012
-
Changes in the burden of malaria in sub-Saharan Africa..
10:545-555.
2010
-
Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries..
9:637-649.
2009